Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 2959-2962, July 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emmert-Buck, M. R.
Right arrow Articles by Linehan, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emmert-Buck, M. R.
Right arrow Articles by Linehan, W. M.

Allelic Loss on Chromosome 8p12–21 in Microdissected Prostatic Intraepithelial Neoplasia

Michael R. Emmert-Buck, Cathy D. Vocke, Rudy O. Pozzatti, Paul H. Duray, Scott B. Jennings, Charles D. Florence, Zhengping Zhuang, David G. Bostwick, Lance A. Liotta and W. Marston Linehan1

Laboratory of Pathology [M. R. E-B., P. H. D., Z. Z, L. A. L.] and Surgical Branch [S. B. J., C. D. V., R. O. P., C. D. F., W. M. L.], National Cancer Institute, Bethesda, Maryland 20892, and Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905 [D. G. B.]

The development and progression of human prostate cancer is associated with genetic abnormalities in tumor cells. Inactivation of tumor suppressor genes due to allelic loss is thought to be an important mechanism of gene alteration in prostatic neoplasms. In this study we examined allelic loss on chromosome 8p12–21 in microdissected samples of normal prostatic epithelium, high grade prostatic intraepithelial neoplasia (PIN), and invasive prostate carcinoma from the same patients. Tissue microdissection under direct microscopic visualization procures pure populations of cells of interest, including small lesions such as PIN. Among 30 patients with concomitant cancer and PIN, we found loss of heterozygosity on chromosome 8p12–21 in 63% (34 of 54) of foci of PIN examined and 90.6% (29 of 32) of tumors, suggesting that abnormalities on chromosome 8p12–21 may be important in the early stages of prostatic carcinoma development. Several cases in which multiple foci of PIN from the same patient were sampled showed different patterns of allelic loss. Fifty-five % (16 of 29) of the prostate carcinomas contained a potential precursor PIN focus based on allelic loss pattern. Our results are consistent with the hypothesis that PIN arises multifocally within the prostate gland, and that a subset of these lesions progress to become carcinoma.

1 To whom requests for reprints should be addressed, at Urologic Oncology Section, Surgery Branch, Building 10, Room 2B47, National Cancer Institute, Bethesda, MD 20892-1502.

Received 4/19/95. Accepted 6/ 2/95.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
L. Guo, D. Zhong, S. Lau, X. Liu, X.-Y. Dong, X. Sun, V. W. Yang, P. M. Vertino, C. S. Moreno, V. Varma, et al.
Sox7 Is an Independent Checkpoint for {beta}-Catenin Function in Prostate and Colon Epithelial Cells
Mol. Cancer Res., September 1, 2008; 6(9): 1421 - 1430.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Pickup and T H Van der Kwast
My approach to intraductal lesions of the prostate gland
J. Clin. Pathol., August 1, 2007; 60(8): 856 - 865.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Hara, S. Samuel, J. Liu, D. Rosen, R. R. Langley, and H. Naora
A Homeobox Gene Related to Drosophila Distal-Less Promotes Ovarian Tumorigenicity by Inducing Expression of Vascular Endothelial Growth Factor and Fibroblast Growth Factor-2
Am. J. Pathol., May 1, 2007; 170(5): 1594 - 1606.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Bowen, A. Stuart, J.-H. Ju, J. Tuan, J. Blonder, T. P. Conrads, T. D. Veenstra, and E. P. Gelmann
NKX3.1 Homeodomain Protein Binds to Topoisomerase I and Enhances Its Activity
Cancer Res., January 15, 2007; 67(2): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. R. Bethel, D. Faith, X. Li, B. Guan, J. L. Hicks, F. Lan, R. B. Jenkins, C. J. Bieberich, and A. M. De Marzo
Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion.
Cancer Res., November 15, 2006; 66(22): 10683 - 10690.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Dai, O. Kim, Y. Xie, Z. Guo, K. Xu, B. Wang, X. Kong, J. Melamed, H. Chen, C. J. Bieberich, et al.
Tyrosine Kinase Etk/BMX Is Up-regulated in Human Prostate Cancer and Its Overexpression Induces Prostate Intraepithelial Neoplasia in Mouse
Cancer Res., August 15, 2006; 66(16): 8058 - 8064.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Li, B. Guan, S. Maghami, and C. J. Bieberich
NKX3.1 Is Regulated by Protein Kinase CK2 in Prostate Tumor Cells
Mol. Cell. Biol., April 15, 2006; 26(8): 3008 - 3017.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. Henrique, C. Jeronimo, M. R. Teixeira, M. O. Hoque, A. L. Carvalho, I. Pais, F. R. Ribeiro, J. Oliveira, C. Lopes, and D. Sidransky
Epigenetic Heterogeneity of High-Grade Prostatic Intraepithelial Neoplasia: Clues for Clonal Progression in Prostate Carcinogenesis
Mol. Cancer Res., January 1, 2006; 4(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Ouyang, T. L. DeWeese, W. G. Nelson, and C. Abate-Shen
Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis
Cancer Res., August 1, 2005; 65(15): 6773 - 6779.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. S. Palapattu, S. Sutcliffe, P. J. Bastian, E. A. Platz, A. M. De Marzo, W. B. Isaacs, and W. G. Nelson
Prostate carcinogenesis and inflammation: emerging insights
Carcinogenesis, July 1, 2005; 26(7): 1170 - 1181.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. E. Wright, D. K. Han, and R. Aebersold
Mass Spectrometry-based Expression Profiling of Clinical Prostate Cancer
Mol. Cell. Proteomics, April 1, 2005; 4(4): 545 - 554.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Asatiani, W.-X. Huang, A. Wang, E. Rodriguez Ortner, L. R. Cavalli, B. R. Haddad, and E. P. Gelmann
Deletion, Methylation, and Expression of the NKX3.1 Suppressor Gene in Primary Human Prostate Cancer
Cancer Res., February 15, 2005; 65(4): 1164 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Adams, S. V. Williams, J. S. Aveyard, and M. A. Knowles
Loss of Heterozygosity Analysis and DNA Copy Number Measurement on 8p in Bladder Cancer Reveals Two Mechanisms of Allelic Loss
Cancer Res., January 1, 2005; 65(1): 66 - 75.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. P. McCarthy, S. Zhang, D. G. Bostwick, J. Qian, J. N. Eble, M. Wang, H. Lin, and L. Cheng
Molecular Genetic Evidence for Different Clonal Origins of Epithelial and Stromal Components of Phyllodes Tumor of the Prostate
Am. J. Pathol., October 1, 2004; 165(4): 1395 - 1400.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ashida, H. Nakagawa, T. Katagiri, M. Furihata, M. Iiizumi, Y. Anazawa, T. Tsunoda, R. Takata, K. Kasahara, T. Miki, et al.
Molecular Features of the Transition from Prostatic Intraepithelial Neoplasia (PIN) to Prostate Cancer: Genome-wide Gene-expression Profiles of Prostate Cancers and PINs
Cancer Res., September 1, 2004; 64(17): 5963 - 5972.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Gary, R. Azuero, G. S. Mohanty, W. C. Bell, I.-E. A. Eltoum, and S. A. Abdulkadir
Interaction of Nkx3.1 and p27kip1 in Prostate Tumor Initiation
Am. J. Pathol., May 1, 2004; 164(5): 1607 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. von Knobloch, L. Konrad, P. J. Barth, H. Brandt, S. Wille, A. Heidenreich, R. Moll, and R. Hofmann
Genetic Pathways and New Progression Markers for Prostate Cancer Suggested by Microsatellite Allelotyping
Clin. Cancer Res., February 1, 2004; 10(3): 1064 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. L. Xu, Y. Shi, G. Petrovics, C. Sun, M. Makarem, W. Zhang, I. A. Sesterhenn, D. G. McLeod, L. Sun, J. W. Moul, et al.
PMEPA1, an Androgen-regulated NEDD4-binding Protein, Exhibits Cell Growth Inhibitory Function and Decreased Expression during Prostate Cancer Progression
Cancer Res., August 1, 2003; 63(15): 4299 - 4304.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. G. Nelson, A. M. De Marzo, and W. B. Isaacs
Prostate Cancer
N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381.
[Full Text] [PDF]


Home page
Cancer Res.Home page
M. J. Kim, R. Bhatia-Gaur, W. A. Banach-Petrosky, N. Desai, Y. Wang, S. W. Hayward, G. R. Cunha, R. D. Cardiff, M. M. Shen, and C. Abate-Shen
Nkx3.1 Mutant Mice Recapitulate Early Stages of Prostate Carcinogenesis
Cancer Res., June 1, 2002; 62(11): 2999 - 3004.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. A. Abdulkadir, J. A. Magee, T. J. Peters, Z. Kaleem, C. K. Naughton, P. A. Humphrey, and J. Milbrandt
Conditional Loss of Nkx3.1 in Adult Mice Induces Prostatic Intraepithelial Neoplasia
Mol. Cell. Biol., March 1, 2002; 22(5): 1495 - 1503.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Kim, R. D. Cardiff, N. Desai, W. A. Banach-Petrosky, R. Parsons, M. M. Shen, and C. Abate-Shen
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
PNAS, February 14, 2002; (2002) 42688999.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Matsuyama, Y. Pan, K. Oba, S. Yoshihiro, K. Matsuda, L. Hagarth, D. Kudren, K. Naito, U. S. R. Bergerheim, and P. Ekman
Deletions on Chromosome 8p22 May Predict Disease Progression As Well As Pathological Staging in Prostate Cancer
Clin. Cancer Res., October 1, 2001; 7(10): 3139 - 3143.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. J. Roth, N. Hu, M. R. Emmert-Buck, Q.-H. Wang, S. M. Dawsey, G. Li, W.-J. Guo, Y.-Z. Zhang, and P. R. Taylor
Genetic Progression and Heterogeneity Associated with the Development of Esophageal Squamous Cell Carcinoma
Cancer Res., May 1, 2001; 61(10): 4098 - 4104.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
J. C. Alers, P.-J. Krijtenburg, A. N. Vis, R. F. Hoedemaeker, M. F. Wildhagen, W. C. J. Hop, T. H. van der Kwast, F. H. Schroder, H. J. Tanke, and H. van Dekken
Molecular Cytogenetic Analysis of Prostatic Adenocarcinomas from Screening Studies : Early Cancers May Contain Aggressive Genetic Features
Am. J. Pathol., February 1, 2001; 158(2): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Bowen, L. Bubendorf, H. J. Voeller, R. Slack, N. Willi, G. Sauter, T. C. Gasser, P. Koivisto, E. E. Lack, J. Kononen, et al.
Loss of NKX3.1 Expression in Human Prostate Cancers Correlates with Tumor Progression1,2
Cancer Res., November 1, 2000; 60(21): 6111 - 6115.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
C. Abate-Shen and M. M. Shen
Molecular genetics of prostate cancer
Genes & Dev., October 1, 2000; 14(19): 2410 - 2434.
[Full Text]


Home page
J. Clin. Pathol.Home page
R. Montironi, R. Mazzucchelli, F. Algaba, and A. Lopez-Beltran
Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance
J. Clin. Pathol., September 1, 2000; 53(9): 655 - 665.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
M. R. Emmert-Buck, R. L. Strausberg, D. B. Krizman, M. F. Bonaldo, R. F. Bonner, D. G. Bostwick, M. R. Brown, K. H. Buetow, R. F. Chuaqui, K. A. Cole, et al.
Molecular Profiling of Clinical Tissue Specimens: Feasibility and Applications
J. Mol. Diagn., May 1, 2000; 2(2): 60 - 66.
[Full Text]


Home page
Am. J. Pathol.Home page
M. R. Emmert-Buck, R. L. Strausberg, D. B. Krizman, M. F. Bonaldo, R. F. Bonner, D. G. Bostwick, M. R. Brown, K. H. Buetow, R. F. Chuaqui, K. A. Cole, et al.
Molecular Profiling of Clinical Tissue Specimens : Feasibility and Applications
Am. J. Pathol., April 1, 2000; 156(4): 1109 - 1115.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Serth, M. A. Kuczyk, U. Paeslack, R. Lichtinghagen, and U. Jonas
Quantitation of DNA Extracted after Micropreparation of Cells from Frozen and Formalin-Fixed Tissue Sections
Am. J. Pathol., April 1, 2000; 156(4): 1189 - 1196.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Sato, J. Qian, J. M. Slezak, M. M. Lieber, D. G. Bostwick, E. J. Bergstralh, and R. B. Jenkins
Clinical Significance of Alterations of Chromosome 8 in High-Grade, Advanced, Nonmetastatic Prostate Carcinoma
J Natl Cancer Inst, September 15, 1999; 91(18): 1574 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. N. Nupponen, L. Kakkola, P. Koivisto, and T. Visakorpi
Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas
Am. J. Pathol., July 1, 1998; 153(1): 141 - 148.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M.-A. Shibata, C. L. Jorcyk, M.-L. Liu, K. Yoshidome, L. G. Gold, and J. E. Green
The C3(1)/SV40 T Antigen Transgenic Mouse Model of Prostate and Mammary Cancer
Toxicol Pathol, January 1, 1998; 26(1): 177 - 182.
[PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Kim, R. D. Cardiff, N. Desai, W. A. Banach-Petrosky, R. Parsons, M. M. Shen, and C. Abate-Shen
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
PNAS, March 5, 2002; 99(5): 2884 - 2889.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.